COL17A1 and pemphigus: Among them, 87% of patients with pemphigus were positive for either anti-Dsg1 and anti-Dsg3 antibodies, and 79.25% of patients with BP were positive for either anti-BP180 and anti-BP230 antibodies (Figure 4B).